Sex Differences in Alzheimer's Disease Mechanisms

Alzheimer’s disease exhibits pronounced sex differences in incidence, progression and pathophysiology. Women are at greater risk of developing dementia and often experience more rapid cognitive decline. Emerging evidence points to sex-specific molecular pathways that modulate amyloid-β accumulation, tau phosphorylation, neuroinflammation and neuronal bioenergetics. Female brains display distinct patterns of gene expression, glial activation and mitochondrial metabolism, influenced in part by hormonal transitions such as perimenopause. In parallel, male subjects show divergent interactions between genetic risk factors, notably the APOE ε4 allele, and sex-biased immune responses. Integrative approaches combining genomics, transcriptomics and imaging have begun to reveal key drivers underpinning these disparities, offering avenues for tailored diagnostic biomarkers and precision therapies.

Research from Nature Portfolio

Recent studies have applied machine-learning to identify coding variants that precipitate sex-specific gene associations in Alzheimer’s disease risk. This approach revealed immune-related pathways predominantly in males, alongside cell-cycle dysregulation in females, and demonstrated the functional impact of candidate genes in in vivo neurodegenerative models. In parallel, investigations of microglial metabolism uncovered sexual dimorphism in glial activation and amyloid clearance. Female microglia were found to adopt a glycolytic phenotype with reduced phagocytic capacity, correlating with elevated plaque burden, whereas male microglia exhibited an amoeboid morphology and enhanced plaque removal. These insights underscore metabolic and immunological underpinnings of sex-dependent vulnerability and suggest glia-targeted interventions.

Sex Differences in Alzheimer's Disease Mechanisms publication trend

The graph below shows the total number of articles in sex differences in alzheimer's disease mechanisms across all publications each year (not limited to Nature Index journals).

Technical terms

Apolipoprotein E ε4 (APOE ε4): A genetic variant associated with increased Alzheimer’s risk and modulated by sex.

Microglia: Resident immune cells of the central nervous system involved in clearance of amyloid plaques and neuroinflammation.

Gene co-expression network: A collection of genes whose expression levels correlate across samples, revealing coordinated regulatory modules.

Glycolysis: The metabolic pathway converting glucose to pyruvate, often altered in neurodegenerative states.

Phagocytosis: Cellular process by which cells engulf and remove debris, including amyloid-β aggregates.

Bioenergetics: The study of energy flow and production within biological systems, crucial for neuronal function.

References

1. Sex specific molecular networks and key drivers of Alzheimer’s disease. Molecular Neurodegeneration (2023).
2. Functional variants identify sex-specific genes and pathways in Alzheimer’s Disease. Nature Communications (2023).
3. Microglial metabolism is a pivotal factor in sexual dimorphism in Alzheimer’s disease. Communications Biology (2021).
4. Perimenopause and emergence of an Alzheimer’s bioenergetic phenotype in brain and periphery. PLOS ONE (2017).
5. Sex differences in the progression of glucose metabolism dysfunction in Alzheimer’s disease. Experimental & Molecular Medicine (2023).